Congress mandates free blood pressure monitors for pregnant women
H.R. 8716 — Blood Pressure MATTERS Act · Filed by Nikema Williams (D-GA) · 6 cosponsors · Introduced May 7, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicaid, CHIP, and private health insurance plans to cover self-measured blood pressure monitoring devices for pregnant and postpartum individuals (up to 12 months after delivery) at no cost to the patient. The device must be FDA-cleared and validated by the American Medical Association. Each person can receive one device per 2-year period. The bill aims to help detect pregnancy-related hypertension and preeclampsia early.
Why we flagged it
The bill's core function is to require insurers to cover a specific preventive device for a defined population (pregnant/postpartum individuals) to address a documented maternal health risk. It is a public-health mandate, not a tax provision, subsidy, or deregulation.
What the text implies
- Device manufacturers (particularly those with AMA-validated products) may see increased demand and market capture, though the bill does not name or favor specific manufacturers.
- States with Medicaid plans may face administrative and fiscal burden to implement coverage within 120 days; the bill includes a grace period for states requiring legislative action.
The full analysis lists 4 implications of this text.
Who stands to gain
manufacturers of FDA-cleared, AMA-validated blood pressure monitoring devices; medical device distributors and suppliers